Toward a Brighter Future in Vaccine Safety Science: A Call For Investments, Capitalizing on Scientific Opportunities and A National Vaccine Safety Board

Clicks: 5
ID: 338037
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #496 of 503 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 503 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The article argues that U.S. vaccine confidence requires an independent National Vaccine Safety Board, expanded real-world surveillance, public-responsive research, and genomic studies to distinguish causal adverse events, identify vulnerable individuals, and improve vaccine safety and trust.
Reference Key
openalex_W7224807336 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag535
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.